University of Arkansas Developing Water Quality Tests with Technology from NOWDiagnostics

Using NOWDx’s rapid-response technology could revolutionize water quality testing around the world

SPRINGDALE, ARK. (March 8, 2016) – NOWDiagnostics Inc., based in Springdale, Ark., is working with students from the University of Arkansas (UA) to develop easy-to-use water quality tests for the Environmental Protection Agency (EPA).

Students in the UA Department of Chemical Engineering were recently awarded a grant from the EPA to develop the water quality tests, which, if successful, will be especially useful in testing water in developing countries around the world. The hand-held tests are small and easy to use and will determine if water contains bacteria or other contaminants that would be dangerous if ingested.

“There are major water quality problems all over the world. Current water testing methods can be cumbersome and expensive,” said Kevin Clark, Chief Executive Officer of NOWDiagnostics.

“We are honored to help these students with this important work, which has the potential to save lives across the globe.”

NOWDiagnostics manufactures and sells a line of unique rapid tests that allow health care providers to conduct simple-to-use, highly accurate tests for a variety of conditions and diseases. NOWDiagnostics’ tests allow for a one-step process that provides results in five to 15 minutes using a variety of sample types with no laboratory needed.

The water quality project, funded through the EPA’s People, Prosperity and the Planet Student Design Competition, will use NOWDiagnostics’ rapid-testing technology. The project, which will be completed in March 2016 when the students present their findings to the EPA, is led by one Ph.D. student and four undergraduate students and overseen by Dr. Robert Beitle, Professor of Chemical Engineering at UA. NOWDx’s rapid-testing technology uses a small plastic device and technology that provides quick results for immediate action.

“I am certainly proud of the work these students are doing, and we are incredibly grateful to NOWDiagnostics for offering their technology and lab space for our use throughout this project,” Beitle said.

Currently, NOWDiagnostics manufactures the ADEXUSDx™ hCG test for distribution in the United States and five additional tests in Europe. All of the launched tests are reviewed by the Federal Drug Administration (FDA) and have proven sensitivity, specificity, accuracy and precision comparable to conventional diagnostic laboratory tests.


NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostic health testing. Its ADEXUSDx® product line features a lab at your fingertip, using only a drop of blood to test for a variety of conditions, illnesses and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to dramatically decrease the waiting period to determine test results.

The company is currently offering an hCG (pregnancy) test in the United States and Europe, and two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.

For more information about NOWDiagnostics, visit